Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective
Article in PharmacoEconomics (May 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Article in PharmacoEconomics (May 2024)
Article in Der Schmerz (August 2023)
Article in Journal of Clinical Neuroscience (May 2023)